证券代码：688053 证券简称：ST 思科瑞 公告编号：2025-046 成都思科瑞微电子股份有限公司 第二届监事会第十一次会议决议公告 具 体 内 容 详 见 公 司 2025 年 10 月 31 日 披 露 于 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）的《成都思科瑞微电子股份有限公司 2025 年第三季度报告》。 （二）审议通过《关于使用部分闲置募集资金进行现金管理的议案》 监事会认为：公司在不影响募集资金投资计划正常进行的前提下，使用部分暂时闲 置募集资金进行现金管理，用于购买安全性高、流动性好、期限不超过 12 个月（含）、 保本型的投资产品（仅限于结构性存款、定期存款、通知存款、大额存单），有利于 提高公司募集资金使用效率，与募集资金投资项目的实施计划不存在抵触，不影响募 1 本公司监事会及全体监事保证本公告内容不存在虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 根据《中华人民共和国公司法》及《公司章程》的有关规定，第二届监事会第十 一次会议于 2025 年 10 月 19 日以专人送达方式发出会议通知 ...

中国银河证券股份有限公司 中国银河证券股份有限公司(以下简称"银河证券"或"保荐机构")作为成都 思科瑞微电子股份有限公司(以下简称"思科瑞"或"公司")首次公开发行股票并 在科创板上市及进行持续督导的保荐机构,根据《上市公司募集资金监管规则》、 《上海证券交易所科创板股票上市规则》和《上海证券交易所科创板上市公司自 律监管指引第1 号 -- 规范运作》等有关法律法规和规范性文件的要求,对思科 瑞拟使用部分闲置募集资金进行现金管理事项进行了核查,并发表核查意见如下: 关于成都思科瑞微电子股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意成都思科瑞微电子股份有限公司首 次公开发行股票注册的批复》（证监许可〔2022〕1115 号》,同意公司首次公 开发行股票的注册申请,并经上海证券交易所同意,公司首次向社会公众公开发 行人民币普通股(A 股)股票 2,500.00 万股,发行价格为每股人民币 55.53元, 募集资金总额为人民币 138,825.00 万元,扣除各项发行费用(不含增值税)人民 币 13,574.34 万元后,实际募集资金净额为人民 ...

Financial Performance - The company's operating revenue for the third quarter was ¥45,567,941.31, an increase of 4.37% compared to the same period last year[4] - The total profit for the third quarter was -¥5,404,387.15, representing a decrease of 268.42% year-on-year[4] - The net profit attributable to shareholders was -¥2,770,406.54, a decline of 166.22% compared to the same period last year[4] - The net profit attributable to shareholders for the year-to-date period was -¥3,543,783.02, down 190.73% year-on-year[4] - Total operating revenue for the first three quarters of 2025 reached ¥146,565,164.08, a significant increase of 47.6% compared to ¥99,252,476.83 in the same period of 2024[21] - The net profit for the first three quarters of 2025 was a loss of ¥3,012,194.26, compared to a loss of ¥515,379.63 in the same period of 2024[21] - The net profit attributable to the parent company shareholders for the current period is 813,790.87 CNY, a decrease of 52.6% compared to 1,715,067.11 CNY in the previous period[22] - The net loss for minority shareholders is -3,825,985.13 CNY, worsening from -2,230,446.74 CNY in the previous period[22] - Basic and diluted earnings per share for the current period are both 0.01 CNY, down from 0.02 CNY in the previous period[22] - The total comprehensive income attributable to the parent company is 813,790.87 CNY, compared to 1,715,067.11 CNY in the previous period[22] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥1,787,083,605.26, a decrease of 1.92% from the end of the previous year[5] - The total assets of the company decreased to ¥1,787,083,605.26 as of September 30, 2025, from ¥1,822,019,588.53 at the end of 2024[18] - The total liabilities decreased to ¥139,335,865.59 as of September 30, 2025, compared to ¥171,259,654.60 at the end of 2024[18] - The company's equity attributable to shareholders was ¥1,608,816,769.76 as of September 30, 2025, slightly up from ¥1,608,002,978.89 at the end of 2024[18] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥5,208,112.41, a decrease of 89.66% compared to the previous year[4] - The net cash flow from operating activities for the first three quarters of 2025 is 5,208,112.41 CNY, down from 50,377,514.48 CNY in the same period of 2024[24] - Cash inflow from investment activities increased to 601,353,055.56 CNY, compared to 476,748,718.85 CNY in the previous year[25] - The net cash flow from investment activities is 253,931,352.39 CNY, a significant improvement from -89,918,478.29 CNY in the previous period[25] - The net cash flow from financing activities is -471,085.45 CNY, compared to -58,699,640.74 CNY in the same period last year[25] - The ending cash and cash equivalents balance is 481,188,315.62 CNY, up from 210,059,495.89 CNY at the end of the previous period[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 4,787[12] - The largest shareholder, Chengdu Quan Jun Enterprise Management Center, holds 54,908,065 shares, representing 54.91% of total shares[12] - The second largest shareholder, Ningbo Tongyuan Youbo Venture Capital Partnership, holds 2,460,000 shares, representing 2.46%[12] - The third largest shareholder, Ningbo Tongtai Xin Venture Capital Partnership, holds 2,410,000 shares, representing 2.41%[12] - The total number of shares held by the top 10 shareholders is significant, with the first three shareholders holding over 59% combined[12] - The company has a repurchase account holding 1,419,877 shares, accounting for 1.42% of total shares[14] - There are no changes in the shareholding structure due to securities lending activities among the top shareholders[15] Regulatory and Compliance Issues - The company is under administrative supervision by the China Securities Regulatory Commission, with corrective measures being implemented[15] - The company has acknowledged issues related to revenue recognition and is taking steps to rectify them[15] - The company plans to disclose further details regarding the administrative measures and corrective actions taken in future reports[15] Research and Development - Research and development expenses totaled ¥5,472,747.74, accounting for 12.01% of operating revenue, a decrease of 2.59 percentage points year-on-year[5] - Research and development expenses for the first three quarters of 2025 were ¥16,218,546.92, a decrease of 14.0% compared to ¥18,870,475.10 in the same period of 2024[21] Operational Insights - The company reported an increase in military industry orders, contributing to the growth in detection orders[9] - The increase in depreciation costs and inventory impairment provisions negatively impacted the net profit for the period[10]

Group 1 - On October 24, five listed companies received penalties from local securities regulatory authorities for violations related to information disclosure, highlighting the regulatory body's commitment to strict enforcement and market environment purification [1] - Information disclosure is a crucial channel for listed companies to reveal their value and is the basis for investors' investment decisions [1] - Companies must fulfill their information disclosure responsibilities and provide investors with accurate and transparent information [1] Group 2 - Baiyin Nonferrous Group Co., Ltd. received a penalty for failing to disclose information regarding the non-recovery of financial investments, amounting to 30 billion yuan, which was not recovered until December 2024 [2][3] - The Gansu Securities Regulatory Bureau imposed a fine of 4 million yuan on Baiyin Nonferrous for significant omissions in its annual reports from 2019 to 2024 [3][4] Group 3 - Changjiang Runfa Health Industry Co., Ltd., which was delisted, received a notice of administrative penalties totaling 53.3 million yuan for failing to disclose related party non-operating fund occupation and significant omissions in periodic reports [5][6] - The Jiangsu Securities Regulatory Bureau proposed fines of 10.5 million yuan for Changjiang Health and 15 million yuan for its controlling shareholder, Runfa Group [5] Group 4 - *ST Xinyuan and ST Sicorui were penalized for fabricating sales and improper revenue recognition, with *ST Xinyuan facing a proposed fine of 8 million yuan [7] - ST Sicorui received a penalty of 2 million yuan for similar violations [7][8] Group 5 - ST Chuangyi was penalized for revenue recognition violations, with the Sichuan Securities Regulatory Bureau imposing a fine of 4 million yuan [8][9] - ST Chuangyi reported overstatements of revenue in its financial statements for 2022 and 2023 [8]

中国经济网北京10月27日讯 中国证券监督管理委员会四川监管局网站近日发布的行政处罚决定书 〔2025〕6号显示，依据《中华人民共和国证券法》（以下简称《证券法》）的有关规定，四川证监局 对成都思科瑞微电子股份有限公司（以下简称"ST思科瑞"，688053.SH）信息披露违法违规行为进行了 立案调查。 经查明，ST思科瑞存在以下违法事实： 一、ST思科瑞虚构销售业务 2022年12月，ST思科瑞虚构一笔与四川赛狄信息技术股份公司（以下简称"赛狄信息"）336.65万元 的检测业务，在未收到待检货物且未真实开展检测业务的情况下，安排人员生成对账单并利用与赛狄信 息相关工作人员私人关系加盖对方公章，导致ST思科瑞2022年分别虚增销售收入和利润总额336.65万 元、318.81万元。 二、ST思科瑞提前确认收入 2022年9月，ST思科瑞在尚未向客户佳缘科技股份有限公司（以下简称"佳缘科技"）交付检测货物 且未经佳缘科技确认对账单情况下确认收入，导致ST思科瑞2022年分别虚增销售收入和利润总额246.93 万元、203.7万元。 三、ST思科瑞不当确认收入 ST思科瑞与佳缘科技于2022年9月签署的两笔结算合 ...

Core Viewpoint - On October 24, six companies, including five listed firms and one delisted company, received administrative penalties from local securities regulatory authorities, totaling fines of 96.8 million yuan, primarily related to violations of information disclosure regulations [1][2]. Summary by Category Penalties and Violations - *ST XinYuan (300472.SZ) received the largest penalty of 16.1 million yuan for falsely reporting revenue, costs, and profits by 52.26 million yuan from May 2022 to June 2024, leading to misleading annual reports [2][3]. - Baiyin Nonferrous (601212.SH) was fined 8.8 million yuan for failing to disclose the specifics of 3 billion yuan in financial products, resulting in significant omissions in annual reports from 2019 to 2024 [3][4]. - ST Chuangyi (300366.SZ) and ST Sike Rui (688053.SH) faced fines of 8 million yuan and 5.6 million yuan, respectively, for overstating revenues in their financial reports [3][4]. - *ST XinChao (600777.SH) was fined 5 million yuan for not disclosing its 2024 annual report on time [4]. - Jiangsu Securities Regulatory Bureau proposed a fine of 53.3 million yuan against the delisted company Changjiang Health for failing to disclose significant non-operating fund occupation [6][7]. Regulatory Focus - The China Securities Regulatory Commission (CSRC) emphasizes the importance of high-quality information disclosure as a key factor in promoting the registration-based IPO system and enhancing the quality of capital markets [5][6]. - The recent penalties reflect a continued effort by regulatory authorities to strengthen oversight of financial reporting and improve regulatory mechanisms [5][6]. Implications for Delisted Companies - The case of Changjiang Health illustrates that delisting does not exempt companies from accountability; rather, it marks the beginning of a new phase of scrutiny and potential penalties for past violations [6][10]. - Regulatory authorities are committed to pursuing legal actions against companies and individuals involved in misconduct, regardless of their listing status [10][11]. Governance Issues - Experts highlight that the concentration of power among controlling shareholders often leads to inadequate internal governance, allowing for the circumvention of normal decision-making processes and the occupation of company funds [9][11]. - There is a call for both internal governance improvements and enhanced external regulatory oversight to effectively combat fund occupation issues prevalent in the A-share market [9].

Core Points - The Shanghai Stock Exchange publicly reprimanded Chengdu Sicor Microelectronics Co., Ltd. and relevant responsible individuals for violations in information disclosure and regulatory operations [1][2] Group 1: Company Violations - Chengdu Sicor Microelectronics fabricated a sales transaction worth 3.3665 million yuan with Sichuan Saidi Information Technology Co., Ltd., resulting in inflated sales revenue and profit by 3.3665 million yuan and 3.1881 million yuan respectively for 2022 [3] - The company recognized revenue prematurely from Jiayuan Technology Co., Ltd. without delivering goods or obtaining confirmation, inflating sales revenue and profit by 2.4693 million yuan and 2.037 million yuan respectively for 2022 [4] - Despite significant disputes over contracts worth 4.1246 million yuan with Jiayuan Technology, the company recognized revenue, leading to inflated sales revenue and profit by 4.1246 million yuan and 1.7803 million yuan respectively for 2022 [5] - Overall, the company inflated its total operating revenue by 9.9604 million yuan and total profit by 7.0054 million yuan, accounting for 4.16% and 6.56% of its total revenue and profit for the same period [5] Group 2: Responsibility and Disciplinary Actions - The responsible individuals, including the chairman, general manager, vice general manager, and financial director, failed to fulfill their duties in ensuring the accuracy and completeness of the company's annual report [6][7] - The Shanghai Stock Exchange's disciplinary committee decided to publicly reprimand the company and the aforementioned individuals based on the violations identified [8] - The company is required to submit a rectification report within one month, signed by all senior management, addressing the compliance issues highlighted in the disciplinary decision [9] Group 3: Company Financials - For the first half of 2025, ST Sicor's revenue was entirely derived from the testing services sector, accounting for 100% of its income [10] - As of the report date, ST Sicor's market capitalization stood at 2.9 billion yuan [11]

证券代码：688053 证券简称：ST思科瑞 公告编号：2025-043 成都思科瑞微电子股份有限公司 关于公司及相关人员收到中国证券监督管理委员会四 川监管局《行政处罚决定书》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 成都思科瑞微电子股份有限公司（以下简称"公司"或"思科瑞"）于 2025 年10月24日收到中国证券监督管理委员会（以下简称"中国证监会"）四川监管 局下发的《行政处罚决定书》（〔2025〕6号），现就具体内容公告如下： 一、《行政处罚决定书》内容 二、思科瑞提前确认收入 "当事人:成都思科瑞微电子股份有限公司(以下简称思科瑞或公司)，住所: 成都市高新区安泰四路68号。 张亚，男，1969年7月出生，时任思科瑞董事长，住址:深圳市福田区。 马卫东，男，1968年10月出生，时任思科瑞董事、总经理,住址:北京市朝 阳区。 舒晓辉，男，1977年11月出生，时任思科瑞副总经理，住址:成都市郫都区。 涂全鑫，男，1987年3月出生，时任思科瑞财务总监，住址:成都市天府新 区。 依据《中华人民共和国 ...

格隆汇10月17日丨ST思科瑞(688053.SH)在互动平台表示，公司目前业务不涉及可控核聚变方面。 ...

Core Viewpoint - The company, Sichuan Sike Rui Microelectronics Co., Ltd., has been involved in financial fraud shortly after its IPO, leading to significant regulatory penalties and a drastic decline in its financial performance [2][3][4]. Financial Fraud - In September 2025, the company was officially renamed "ST Sike Rui," revealing its financial manipulation practices that inflated revenue and profits during its first year of listing [2]. - The Sichuan Securities Regulatory Bureau issued a notice detailing the company's fraudulent activities in 2022, which included fabricating sales, prematurely recognizing revenue, and improper income recognition, resulting in inflated revenue of 9.96 million and inflated profit of 7.01 million, accounting for 4.16% and 6.56% of the respective metrics [3]. - Specific fraudulent actions included generating 3.37 million in detection revenue without actual services and recognizing 2.47 million in revenue before delivering goods, despite disputes with clients [3][4]. Regulatory Actions - The company received a warning and a fine of 2 million, with penalties imposed on several executives, including 1.2 million on the vice president for orchestrating the fraud [4]. - The leniency in handling the executives raised concerns about the company's commitment to rectifying its issues [4]. Performance Decline - The company's financial performance deteriorated sharply post-IPO, with revenue growth of only 4.87% in 2022 despite fraudulent activities, and a net profit decline of 5.77% [5]. - By 2023, revenue fell by 13.75% to 201 million, and net profit halved to 47.84 million, with further declines in 2024 leading to a loss of 210 million [5][6]. Operational Challenges - The company's gross margin decreased from a high level to 36.3% by the end of 2024, with net profit margins turning negative [6]. - The core business, primarily military electronic component reliability testing, faced significant revenue drops, with military client income plummeting by 62.99% [6][7]. Strategic Missteps - The company engaged in aggressive expansion post-IPO, investing over 20.52 million in new testing capabilities, but failed to convert this into competitive advantage, leading to increased operational costs [7]. - Management instability, including the resignation of the general manager and subsequent leadership changes, further exacerbated the company's strategic challenges [7]. Industry Context - The military detection industry is characterized by high dependency on government budgets and pricing controls, making it vulnerable to trust issues and market fluctuations [10]. - The company's loss of credibility could jeopardize its military testing qualifications, which are critical for its survival in the industry [8][9].